Y-mAbs Therapeutics, Inc.
YMAB$450M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaPRINCETON
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Apr 15, 2026
4wMarket Overview
Stock performance and key metrics
YMAB News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GM-CSF + Naxitamab | Phase 2 | Neuroblastoma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply